Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 10—October 2024
Dispatch
Oropouche Fever, Cuba, May 2024
Suggested citation for this article
Abstract
Phylogenetic analyses showed that the virus responsible for a May 2024 Oropouche fever outbreak in Cuba was closely related to viruses from Brazil in 2023. Pools of Ceratopogonidae spp. biting midges and Culex quinquefasciatus mosquitoes were positive for Oropouche viral RNA. No cases were severe. Virus extension to new areas may increase case numbers and severity.
On May 9, 2024, the Pan American Health Organization reported 5,193 cases of Oropouche fever (also called Oropouche virus disease) in Bolivia, Brazil, Colombia, and Peru and sent an alert with regard to autochthonous cases in areas of Brazil and Bolivia, where the disease had not been previously reported (1). During the past decade, Oropouche fever has been reported mainly in the Amazon region. However, in 2014, the first case outside that region was registered in Haiti, raising concerns about its geographic extension (2). The virus has been detected in Central and South America (e.g., Bolivia, Brazil, Colombia, Peru, and Panama); ≈500,000 cases have been diagnosed. Given the clinical picture of Oropouche fever (fever, headache, arthralgia, myalgia), the disease can be confused with dengue, Zika, or other febrile illnesses.
Oropouche virus (OROV) is a member of the family Peribunyaviridae, genus Orthobunyavirus, and was first identified in Trinidad and Tobago. OROV is maintained in nature through sylvatic and urban cycles. The urban cycle is thought to mainly involve the bite of the Culicoides paraensis midge. Another urban vector in tropical regions, where it feeds on both humans and animals, is the Culex quinquefasciatus mosquito (3). The OROV genome comprises 3 single-stranded negative-sense RNA segments (large, medium, and small). Sequencing studies of the small segment suggest the existence of 4 genotypes (I–IV) (4,5).
The source of patients for dengue surveillance in Cuba is the primary healthcare level search, clinical management, and notification of acute febrile illness (AFI) cases of unknown etiology or cases suspected of being dengue. A network of 30 laboratories with capacity for dengue IgM detection guarantees serologic surveillance conducted on samples collected at day 6 of fever onset. Positive samples are confirmed at the National Reference Laboratory of the Institute “Pedro Kouri” (NRL-IPK). Molecular surveillance at the NRL-IPK enables real-time PCR identification of dengue viruses in acute-phase samples from patients with suspected cases. Negative samples are tested for Zika, chikungunya, and yellow fever viruses. The NRL-IPK is also in charge of virus genetic surveillance (6). Environmental and entomologic surveillance complement the national integrated arbovirus surveillance system.
On May 20, 2024, the NRL-IPK received samples from 89 patients with AFI of unknown etiology in Santiago de Cuba and Cienfuegos Provinces, Cuba, where an increase of similar cases had been reported, most negative for dengue IgM. Patients reported acute fever onset with headache and joint pain for 2–3 days and rapid recovery. Median patient age was 35 years (interquartile range [IQR] 19–50); 49.4% of patients were female and 51.6% male. Of the 89 serum samples received, 69 were from Santiago de Cuba (Boniato, n = 39; Songo la Maya, n = 30) and 20 from Cienfuegos (Abreu, n = 4; Cienfuegos, n = 11; and Rodas, n = 5). Urine (n = 6) and feces (n = 30) samples were also collected from the 89 patients.
We extracted RNA by using the commercial QIAamp Viral RNA Mini Kit (QIAGEN, https://www.qiagen.com) according to the manufacturer’s instructions. We processed extracted RNA for dengue, Zika and chikungunya viruses by using by real-time PCR (7–9), and all serum samples were negative. Rapid test results for dengue nonstructural protein 1 (Bioline Dengue Duo; Abbott Laboratories, https://www.abbott.com) and chikungunya IgM (Kabla Diagnósticos, https://www.biodiagnosticos.com) were also negative. Fecal samples were negative for enterovirus (10).
We examined 89 serum and 6 urine samples for Oropouche and Mayaro viruses by using real-time PCR (11). All samples were negative for Mayaro virus, and 74 (83. 1%) serum samples (54 from Santiago de Cuba and 20 from Cienfuegos) and 5 (83.3%) urine samples were positive for OROV.
For the viral genetic characterization, we studied 9 serum samples (3 from Boniato, 3 from Songo La Maya, and 3 from Cienfuegos). We subjected extracted RNA to reverse transcription by PCR using the QIAGEN OneStep RT-PCR Kit system and primers NORO5 (5′-AAAGAGGATCCAATAATGTCAGAGTTCATTT-3′) and ORON3 (5′-AATTCGGAATTGGCATATAGTGGAATTCAC-3′) (12). We purified the 626-bp fragments obtained, which encode for the viral nucleocapsid (positions 85–718), by using the QIAquick PCR Purification Kit (QIAGEN), followed by sequencing with the Dye Terminator Cycle Sequencing Quick Start Kit (Analis, https://www.analis.com) and primers NORO5, ORON3, OROV-F (5′-TCCGGAGGCAGCATATGTG-3′), and OROV-R (5′-AAGTGCTCAATGCTGGTGTTGT-3′) (donated by the Pan American Health Organization). We purified the sequencing products and then separated the generated fragments on a CEQ 8800 Genetic Analysis System sequencer (Analis). We edited and assembled the electropherograms by using Sequencher version 4.10.1 software (Gene Codes Corporation, https://www.genecodes.com). As a reference, we used the complete sequence of the small segment of the Oropouche orthobunyavirus strain (GenBank accession no. OP244879.1, Oropouche orthobunyavirus isolate 0200178W, small segment, complete sequence). Phylogenetic analyses (MEGA version 6) (13) revealed that the isolated viruses clustered in a separate branch, closely related to those reported from Brazil in 2023 (Figure 1).
After we had identified OROV transmission, national surveillance for dengue and Oropouche fever was intensified (active AFI case search). In addition, vector control intervention (adulticide treatment, source reduction, environmental management, biolarvicide application on permanent breeding sites) was applied in the areas with confirmed transmission.
During May 28–June 3, 2024, we processed 31 serum samples collected from locations with increased AFI cases (San Nicolas de Bari in Mayabeque; Perico, Cienaga de Zapata, and Jovellanos in Matanzas; and Ranchuelo in Villa Clara). OROV infection was confirmed in 25 (80.6%) samples: 7 from Matanzas, 9 from Mayabeque, and 9 from Villa Clara Provinces (Table 1). Median patient age was 34.5 years (range 4–83 years), male:female ratio was 1.1. Signs and symptoms by order of frequency were fever, headache, general malaise, myalgia, and arthralgia (Table 2; Figure 2; Appendix Table). No serious or fatal cases were reported.
To investigate the vector involved with OROV transmission in Cuba, we collected 156 C. quinquefasciatus mosquitoes and 49 Ceratopogonidae spp. from suspected areas of transmission in 5 blocks of houses in Boniato. After potential vector identification, we grouped not visibly engorged female C. quinquefasciatus mosquitoes into 9 pools (10–20/pool) and Ceratopogonidae spp. specimens into 2 pools (7–19/pool). We extracted RNA and conducted real-time PCR. Positive samples were attributed to 5 (56%) pools of C. quinquefasciatus mosquitoes and 1 (50%) pool of Ceratopogonidae biting midges.
Among our study limitations was collection of signs/symptoms by using a standardized form for AFI or dengue cases; consequently, we might have missed less common presentations such as meningitis. In addition, the presence of viral RNA does not confirm the vector role in virus transmissibility. More work is needed to determine the primary vectors responsible for the current outbreak.
Oropouche fever is an emerging disease of concern in South and Central America. Transmission outside of the Amazon region is probably silent and not detected by public health surveillance systems. Our results confirm an outbreak of OROV in Cuba. Transmission was detected in semi-urban localities of 5 of 16 provinces located in the western, central, and eastern parts of the country. Dengue surveillance enabled us to identify cases with nondengue AFI. As of August 2024, OROV transmission had been confirmed in 7 provinces. The outbreak in Cuba alerts the Americas and the world of the need for integrated dynamic surveillance systems to detect the introduction and early transmission of OROV and consequently implement effective measures for its control.
Ms. Benitez is a microbiologist at the Institute of Tropical Medicine “Pedro Kouri” in Havana, Cuba, pursuing a master’s degree in virology. Her primary research interests are the arboviral infections, including viral molecular diagnosis.
Acknowledgments
We thank Jairo Mendez, Leticia Franco, Felipe Naveca, and Yosiel Molina for their useful comments and recommendations.
This work was funded by the Cuban Ministry of Health. Real-time PCR reagents were provided by the Pan American Health Organization.
M.G.G., S.R., and V.K. coordinated and designed the study, analyzed the results, and drafted and reviewed the manuscript; M.A. conducted the laboratory work, analyzed the results, and cleaned the data; A.J.B., S.S., and M.P. performed all real-time PCRs; L.P., R.G., and M.P. performed the genetic characterization; G.G., Y.M., and A.C. performed the vector studies; and C.P., J.R.A., and M.R. coordinated the epidemiologic and field studies; and D.C. and I.B. collected the clinical and epidemiologic data. All authors reviewed the draft and approved the final version.
References
- Pan American Health Organization/World Health Organization. Alerta Epidemiológica: oropouche en la región de las Américas, 9 de mayo del 2024 [cited 2024 May 12]. https://www.paho.org/es/documentos/alerta-epidemiologica-oropouche-region-americas-9-mayo-2024
- Elbadry MA, Durães-Carvalho R, Blohm GM, Stephenson CJ, Loeb JC, White SK, et al. Orthobunyaviruses in the Caribbean: Melao and Oropouche virus infections in school children in Haiti in 2014. PLoS Negl Trop Dis. 2021;15:
e0009494 . DOIPubMedGoogle Scholar - Cardoso BF, Serra OP, Heinen LB, Zuchi N, Souza VC, Naveca FG, et al. Detection of Oropouche virus segment S in patients and inCulex quinquefasciatus in the state of Mato Grosso, Brazil. Mem Inst Oswaldo Cruz. 2015;110:745–54. DOIPubMedGoogle Scholar
- Travassos da Rosa JF, de Souza WM, Pinheiro FP, Figueiredo ML, Cardoso JF, Acrani GO, et al. Oropouche virus: clinical, epidemiological, and molecular aspects of a neglected orthobunyavirus. Am J Trop Med Hyg. 2017;96:1019–30. DOIPubMedGoogle Scholar
- Files MA, Hansen CA, Herrera VC, Schindewolf C, Barrett ADT, Beasley DWC, et al. Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development. NPJ Vaccines. 2022;7:38. DOIPubMedGoogle Scholar
- Guzmán MG, Vázquez S, Álvarez M, Pelegrino JL, Ruiz Amores D, Martínez PA, et al. Vigilancia de laboratorio de dengue y otros arbovirus en Cuba, 1970–2017. Rev Cubana Med Trop. 2019;71.
- Santiago GA, Vergne E, Quiles Y, Cosme J, Vazquez J, Medina JF, et al. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis. 2013;7:
e2311 . DOIPubMedGoogle Scholar - Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232–9. DOIPubMedGoogle Scholar
- Johnson BW, Russell BJ, Goodman CH. Laboratory diagnosis of chikungunya virus infections and commercial sources for diagnostic assays. J Infect Dis. 2016;214(suppl 5):S471–4. DOIPubMedGoogle Scholar
- Nijhuis M, van Maarseveen N, Schuurman R, Verkuijlen S, de Vos M, Hendriksen K, et al. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J Clin Microbiol. 2002;40:3666–70. DOIPubMedGoogle Scholar
- Naveca FG, Nascimento VAD, Souza VC, Nunes BTD, Rodrigues DSG, Vasconcelos PFDC. Multiplexed reverse transcription real-time polymerase chain reaction for simultaneous detection of Mayaro, Oropouche, and Oropouche-like viruses. Mem Inst Oswaldo Cruz. 2017;112:510–3. DOIPubMedGoogle Scholar
- Vasconcelos HB, Nunes MRT, Casseb LMN, Carvalho VL, Pinto da Silva EV, Silva M, et al. Molecular epidemiology of Oropouche virus, Brazil. Emerg Infect Dis. 2011;17:800–6. DOIPubMedGoogle Scholar
- Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725–9. DOIPubMedGoogle Scholar
- Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16:111–20. DOIPubMedGoogle Scholar
Figures
Tables
Suggested citation for this article: Benitez AJ, Alvarez M, Perez L, Gravier R, Serrano S, Hernandez DM, et al. Oropouche fever, Cuba, May 2024. Emerg Infect Dis. 2024 Oct [date cited]. https://doi.org/10.3201/eid3010.240900
Original Publication Date: September 10, 2024
1These authors contributed equally to this article.
Table of Contents – Volume 30, Number 10—October 2024
EID Search Options |
---|
|
|
|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Maria G. Guzman, Instituto Medicina Tropical Pedro Kouri, Autopista Novia del Mediodía Km 6 1/2, Havana Lisa 11600, Cuba
Top